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1. Main Messages
•	 Psychological	and/or	pharmacological	treatment	for	people	who	are	at	“ultra-high	risk”	for	psychosis	provides	
excellent	value	for	money	though	further	evidence	of	intervention	effectiveness	is	required
2. Background
The	term	“psychotic	disorders”	is	an	umbrella	term	encompassing	a	broad	range	of	disorders	including,	but	not	
limited	to,	bipolar	disorder,	schizophrenia,	depression	with	psychotic	features	and	schizoaffective	disorder.	The	most	
common	psychotic	disorder	is	schizophrenia,	though	there	is	also	considerable	heterogeneity	in	the	way	in	which	
schizophrenia	presents	between	different	people.	It	has	been	traditionally	thought	that	psychotic	disorders	were	
not	preventable,	with	recent	literature,	largely	pioneered	here	in	Australia	by	Professor	Pat	McGorry	and	colleagues,	
focusing	on	early	detection	and	treatment	of	such	disorders	during	the	“critical”	or	early	phase	of	treatment	to	try	and	
improve	the	prognosis	associated	with	such	conditions.	However	more	recently,	thinking	has	shifted	to	more	indicated	
interventions	for	the	prevention	and	possible	amelioration	of	psychotic	disorders	if	they	become	manifest.	These	
indicated	interventions	identify	young	people	(usually	aged	between	15-25)	who	are	at	“ultra	high”	risk	of	psychosis.	
Professor	McGorry	and	colleagues	at	the	Orygen	Research	Centre	have	been	instrumental	in	developing	the	criteria	
by	which	“ultra-high”	risk	is	defined	and	includes	criteria	such	as	those	found	in	the	prodromal	state	of	schizophrenia	
(simply	defined	as	a	period	of	time	before	the	emergence	of	frank	psychotic	symptoms	when	“something	is	not	quite	
right”)	as	well	as	marked	deterioration	in	functioning	(McGorry,	Yung	et	al.	2002).	Furthermore	it	is	usually	only	youth	
who	seek	help	that	are	offered	such	interventions	as	such	symptoms	can	be	quite	common	in	youth	of	this	age	so	the	
possibility	of	very	high	false-positives	needs	to	be	balanced	against	targeting	the	youth	who	will	benefit	from	such	
interventions	(Yung,	McGorry	et	al.	2007)
3. interventions
There	are	three	studies	which	evaluate	the	treatment	of	youth	who	are	at	ultra-high	risk	for	psychosis,	one	is	
a	pharmacological	and	psychological	intervention	undertaken	here	in	Australia	by	Professor	Pat	McGorry	and	
colleagues,	the	other	is	a	cognitive	therapy	intervention	and	the	third	is	pharmacological	in	nature	(olanzapine).	As	all	
three	interventions	are	different	and	the	Australian	study	involves	a	combination	approach	based	on	individual	need	
we	used	the	Australian	intervention	and	associated	costs	as	the	model	intervention.nHMrc grant no. 351558
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4. cHoice of coMparator
The	comparator	is	“treatment	as	usual”	which	tends	to	consist	of	supportive	psychotherapy	or	monitoring.	
5. intervention cost-effectiveness
Treatment	of	youth	at	ultra-high	risk	for	psychosis	for	the	prevention	of	psychotic	disorders	was	found	to	be	very	cost-effective,	with	96.4%	of	
the	iterations	(with	cost-offsets)	being	either	dominant	(cost	and	health	saving)	or	below	the	$50,000/DALY	threshold	(Figure	1).		When	no	cost-
offsets	are	included,	63%	of	the	iterations	fall	below	the	$50,000/DALY	averted	threshold.
Figure	1	Cost-effectiveness	of	prevention	of	psychotic	disorders	on	a	cost-effectiveness	plane	with	$50,00	per	DALY	threshold	line
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The comparator is “treatment as usual” which tends to consist of supportive psychotherapy 
or monitoring.  
 
5. Intervention cost-effectiveness 
Treatment of youth at ultra-high risk for psychosis for the prevention of psychotic disorders 
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6. Conclusions 
An intervention such as the Australian specific intervention for ultra-high risk youth offered 
through the Australian PACE clinic represents excellent value for money and has the 
potential to save more resources than what it costs, even if the benefit is a delay to 
psychosis progression rather than total prevention per se. This is the first study to consider 
the cost-effectiveness of such interventions. 
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6. conclusions
An	intervention	such	as	the	Australian	specific	intervention	for	ultra-high	risk	youth	offered	through	the	Australian	PACE	clinic	represents	
excellent	value	for	money	and	has	the	potential	to	save	more	resources	than	what	it	costs,	even	if	the	benefit	is	a	delay	to	psychosis	progression	
rather	than	total	prevention	per	se.	This	is	the	first	study	to	consider	the	cost-effectiveness	of	such	interventions.
A	major	limitation	of	the	current	study	is	that	the	long-term	epidemiology	of	the	cohort	of	young	people	eligible	for	these	interventions	is	not	
well	established.	
Other	health	benefits	of	such	interventions	have	not	been	captured	by	the	current	analysis	–	such	as	the	earlier	detection	of	young	people	with	
an	actual	psychotic	disorder	as	well	as	health	benefits	to	the	families	and	carers	of	these	young	people.	Furthermore	it	has	been	shown	that	these	
intervention	may	even	ameliorate	psychotic	disorders	once	they	become	manifest	–	both	in	term	of	clinical	outcomes	and	resource	use	(Phillips,	
McGorry	et	al.	2007).	Therefore,	there	may	be	even	greater	savings	associated	with	the	treatment	of	existing	psychotic	disorders.	However,	
there	may	be	adverse	consequences	to	those	unnecessarily	treated	who	would	not	have	gone	on	to	have	psychosis	–	though	it	must	be	kept	in	
mind	that	these	youth	were	referred	by	a	third	party	for	psychological	assistance	and	were	already	experiencing	some	psychological	distress,	
regardless	of	whether	they	would	have	gone	on	to	develop	psychosis	or	not	–	therefore	it	is	unlikely	that	“extra	harm”	would	be	created	by	such	
an	intervention.
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For	more	information	on	this	topic	area,	please	visit	website	www.sph.uq.edu.au/bodce-ace-prevention
8. aBout ace-prevention
To	aid	priority	setting	in	prevention,	the	Assessing	Cost-Effectiveness	in	Prevention	Project	(ACE-Prevention)	applies	standardised	evaluation	
methods	to	assess	the	cost-effectiveness	of	100	to	150	preventive	interventions,	taking	a	health	sector	perspective.	This	information	is	intended	
to	help	decision	makers	move	resources	from	less	efficient	current	practices	to	more	efficient	preventive	action	resulting	in	greater	health	gain	
for	the	same	outlay.
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indigenous population results 
1.			Cardiovascular	disease	prevention	
2.			Diabetes	prevention	
3.			Screening	and	early	treatment	of	chronic	kidney	disease
overall results 
1.			League	table	
2.			Combined	effects	
General population results
1.		 Adult	depression
2.		 Alcohol
3.		 Blood	pressure	and	cholesterol	lowering
4.		 Cannabis
5.		 Cervical	cancer	screening,	Sunsmart	and	PSA	screening
6.		 Childhood	mental	disorders
7.		 Fruit	and	vegetables
8.	 HIV
9.	 Obesity
10.	 Osteoporosis
11.	 Physical	activity
12.	 Pre	diabetes	screening
13.	 Psychosis
14. Renal replacement therapy, screening and early treatment of chronic kidney disease
15. Salt
16. Suicide prevention
17. Tobacco 
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